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we have assessed a genetic resistance approach based on antisense RNA to interfere with the prototype Minute Virus 
of Mice (MVMp), an autonomous parvovirus. MVMp is a cytolytic virus when infecting the permissive A9 mouse fibroblast 
cell line, and its gene expression is largely regulated at the level of transcription initiation by the nonstructural transactivator 
NS-1 protein, a multifunctional polypeptide also involved in viral DNA replication and cytotoxicity. An NS-1 specific antisense 
RNA constitutively expressed in transfected A9 clones increased several fold the proliferative viability of the cells upon 
high multiplicity virus infection, and cultures infected at low multiplicity reached confluence overcoming virus progression. 
All clones shared a common phenotype of resistance characterized by a lowered synthesis of viral DNA replicative intermedi- 
ates and genomic forms, a significant reduction in the accumulation of the three viral messengers in the cytoplasmic and 
nuclear compartments, and a specific inhibition in viral protein synthesis. These results indicate that the constitutive 
antisense RNA mediates an overall repression of viral macromolecular synthesis by preventing the onset of NS-1 functions. 
Therefore, cytocidal parvoviruses may be hampered by engineered antisense RNA targeted against early regulators of virus 
growth. © 1995 Academic Press, Inc. 
INTRODUCTION 
Many viruses have evolved mechanisms to evade host 
surveillance, such as: local epithelia infections, neural 
latency, genetic variation of neutralizing epitopes, anti- 
gen mimicry or immunosuppression, and other alter- 
ations of the immune defenses homeostasis. Viruses that 
harbor two or more of these capacities, like the lympho- 
tropic human immunodeficiency viruses (Levi, 1993), con- 
stitute unresolved biomedical challenges as they are 
controlled neither by the available chemotherapy nor by 
classical or recombinant vaccines. From the knowledge 
0fvirus genomes' organization and their regulation path- 
ways, new approaches are being explored to control 
these infections, based on the expression in the target 
cells of manipulated viral genes or sequences with antivi- 
ral properties. The concept of creating stable genetically 
engineered resistance was named "intracellular immuni- 
zation" (Baltimore, 1988) and covers a panoply of strate- 
gies like the expression of trans-dominant negative mu- 
tants of regulatory factors (Friedman eta/., 1988; Green 
etaL, 1989; Herskowitz, 1987), structural proteins of the 
capsid (Trono et aL, 1989) or of the virus envelope (Freed 
etaL, 1992), antisense RNA (Coleman et aL, 1985; To et 
a/., 1986), ribozymes (Sawer et aL, 1990; Xing and Whit- 
ton, 1993), or regulatory RNA (Sullenger et aL, 1990a). 
~To whom correspondence and reprint requests should be ad- 
dressed. Fax, 34-1-397 47 99. 
RNA-mediated resistance should be advantageous since 
noncoding sequences are supposed to produce minimal 
harmful effects in the cells, and the mechanism of action 
must be specifically regulated at the level of nucleic acid 
sequence. This hypothesis is supported by the occur- 
rence of endogenous antisense RNA as a physiological 
mechanism of gene regulation (Hildebrandt and Nellen, 
1992; Kimelman and Kirschner, 1989; Mizuno etaL, 1984). 
A wide use of the antisense technology still demands 
better knowledge of the factors that drive the process 
inside the cell, like the secondary and tertiary structures 
of both target and antisense sequences, accessibility of 
regions free from protein complexes, or the elements of 
stability and subcellular distribution of a certain RNA. In 
spite of the lack of a satisfactory rationale for the anti- 
sense design, and the many known examples in which 
it has led to unpredictable failures, a broad repertoire 
of genes has been empirically inhibited by antisense 
(reviewed in Erickson and Izant, 1992; Hawkins and 
Krieg, 1993) and this is one of the leading approaches 
toward the protection of plants against viruses (Day et 
al., 1991' Hemenway eta/., 1988). Among animal viruses, 
pioneer studies of inhibition by constitutive antisense 
expression were conducted in the retrovirus family 
(Chang and Stoltzfus, 1985; To et al., 1986). For these 
viruses, both the targeted regions of the genome (Scza- 
kiel and Pawlita, 1991; von ROden and Gilboa, 1989) and 
the delivery (Sullenger et al., 1990b; Chatterjee et al., 
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1992) were important issues for inhibition. However, the 
extent to which other animal virus families, particularly 
cytolytic viruses, can be inhibited by stably expressed 
antisense RNA remains largely unexplored. 
Viruses whose transcription and translation are sub- 
cellularly or temporally uncoupled processes are prefer- 
ential candidates for an antisense RNA therapy. In this 
report we describe the extension of the constitutive anti- 
sense methodology to the autonomous parvoviruses, a 
genus of nuclear nonenveloped single-stranded DNA vi- 
ruses (Berns, 1990) that includes highly pathogenic 
strains for human and animals with depressed or unde- 
veloped immunological defenses (reviewed in Tijssen, 
1990). Most autonomous parvoviruses possess a small 
genome organized as two transcription units (Cotmore 
and Tattersall, 1987) governed by the transactivator NS- 
1 (Ahn et al., 1992; Doerig et al., 1988; Legendre and 
Rommelaere, 1992; Rhode, 1985), a cytotoxic (Caillet- 
Fauquet et aL, 1990) and multifunctional protein that is 
also involved in viral DNA replication and genome pack- 
aging (Cotmore and Tattersall, 1992; Hanson and Rhode, 
1991). The prototype strain of the parvovirus Minute Virus 
of Mice (MVMp)is markedly cytolytic for the murine fibro- 
blast A9 cell line. Viral messengers accumulate to high 
Levels in the nucleus as well as in the cytoplasm (Scho- 
borg and Pintel, 1991), and virus DNA and proteins be- 
come prominent components of the infected cell. To 
assay a genetic resistance approach in this permissive 
system, an antisense RNA targeted against the MVMp 
NS-1 protein was stably expressed in A9 cells, and its 
antiviral effectiveness was evaluated in terms of protec- 
tion from cytotoxicity, specificity and extension of virus 
inhibition, and the level at which the viral macromolecular 
synthesis was being affected. 
MATERIALS AND METHODS 
Cells and viruses 
The initial virus inoculum of the prototype MVMp virus, 
and a clone of the mouse fibroblast A9 cell line (a variant 
of mouse L cells; Littlefield, 1964) selected for highest 
susceptibility to MVMp virus, were kindly provided by 
J. Rommelaere (DKFZ, Heidelberg). NIH3T3 cells were 
obtained from R. Bravo (Squidd, Princenton). Cells were 
grown in DME medium supplemented with 5% fetal calf 
serum (FCS) and seeded with 10% FCS the day before 
the experiments. The Vesicular Stomatitis Virus (VSV), 
Herpes Simplex Virus type 1 (HSV-1), and Encephalomyo- 
carditis Virus (EMCV) were a gift of L Carrasco (CBM, 
Madrid). MVMp inocula were prepared from density gra- 
dient-purified virus as previously described (Santar6n et 
aL, 1993). 
Cell transfection 
Routinely, 2.5 X 105 growing A9 ceils were seeded in 
60-mm-diameter dishes a day before and transfeoted by 
a conventional calcium phosphate precipitate procedure 
with 10 #g of CsCI gradient-purified plasmid DNA per 
dish. The plasmid pSV2neo (Southern and Berg, 1982) 
carrying the bacterial aminoglycoside phosphotransfer- 
ase gene that confers resistance to neomycin analogs 
was spotted on the cells either alone or together with a 
10-fold molar excess of the pSkNS-la plasmid. Cells 
were grown in normal medium for 2 days and then main- 
tained in medium containing the selective antimetabolite 
geneticin (Sigma) at 400 #g/ml active product, 2 weeks 
before isolation of individual colonies. Clones were 
picked and subcultured twice under selection before be- 
ing analyzed. 
Assays of cellular resistance and viability 
Resistance against MVMp was primarily determined 
by a quantitative assay adapted from Lewis eta/. (1989). 
Cells were plated (104 cells/cm 2) in 35-mm dishes and 
infected 24 hr later at a m.o.i, of 0.1 PFU/celI. After ad- 
sorption and removal of the inocula, DME medium with 
5% FCS was added and infection allowed to proceed for 
6 days. Attached cells were washed three times with 
phosphate-buffered saline (PBS) and fixed and stained 
with 0.25% methyl violet, 50% ethanol, 2% formaldehyde, 
and 0.9% NaCI for 2 hrs. The dishes were washed exten- 
sively with tap water, then air dried, and the dye was 
eluted with 1 ml per 35-ram dish of 50% ethanol, 0.5 M 
NaCI. Optical density at 540 nm was measured in the 
linear range of a Shimadzu UV-1203 spectrophotometer. 
Dishes without seeded cells that were incubated the 6 
days with medium stained with dye to give an ab- 
sorbance of 0.1-0.15 that was subtracted from all the 
values. 
Cell viability was measured as the proliferative ability 
to produce colonies on plastic petri dishes, following 
the assay described by Cornelis et aL (1988) with minor 
modifications. Briefly, cells were seeded at a density of 
104 cells/cm 2 in 35-mm dishes and infected once ad- 
hered at m.o.i. 0.5, 2, 5, and 10 PFU/ceII. Four hours 
postinfection cultures were harvested by trypsinization 
and plated at various densities (2 x 102 to 104 cells per 
60-mm dish) in triplicate to obtain a number of statisti- 
cally representative isolated clones. Cells were incu- 
bated for 15 days in DME supplemented with 10% FCS 
and a neutralizing dilution of MVMp purified capsid anti- 
serum to block reinfection of growing cells. Colonies 
were fixed in absolute methanol, stained with 1% crystal 
violet, and scored under a Gallenkamp colony counter. 
Molecular cloning of MVMp genome 
The entire MVMp genome was cloned in plasmid as 
a source of viral DNA to derive the required constructs. 
Low-molecular-weight intracellular DNA was prepared 
from MVMp-infected A9 cells by a modified Hirt method 
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(McMaster et aL, 1981). The sample was enriched in 
fast-renaturing replicative forms that possess one or two 
hairpins (Ward and Dadachanji, 1978) by heating at 100 ° 
and quick-cooling in ice, followed by two extractions with 
phenol in 500 mM NaCI to get rid of the bulk of single- 
stranded DNA. Mung bean nuclease (Amersham) was 
added (0.1 u/#l) to 5 /~g of DNA in 20 /~1 reaction and 
incubated 30 min at 30 ° to nick hairpins. DNA ends were 
polished with the Klenow polymerase and ligated to 
BamHI linkers (Boerhinger) and the 5-kbp RF viral DNA 
was excised from a low-melting agarose gel (Seakem, 
FMC). Cloning was into the pUC19 vector and the DNA 
transformed in a JM109 bacteria host. Plasmid clones 
were hybridized with a filled-in ssDNA viral probe and 
their termini sequenced by the dideoxy method using the 
direct and reverse universal M13/pUC oligonucleotide 
primers (Boehringer). When compared with the MVMp 
consensus sequence (Astell et al., 1986), a few point 
mutations, insertions, and deletions were detected at the 
turnpoint of the 3' hairpin and at mismatches of both 
termini (not shown). 
RNA purification 
Total RNA was prepared by disrupting the cells in gua- 
nidinium and centrifugation through a cushion (Chirwin 
et al., 1979). Alternatively, a modification of the AGPC 
method (Chomczynski and Sacchi, 1987) was employed. 
Cell monolayers were washed in cold PBS and scrapped 
in solution D (4 M guanidinium thiocyanate, 25 mM so- 
dium citrate, pH 7, 0.5% sarcosyl, 0.1 M 2-mercaptoetha- 
n01). DNA was sheared by syringe with a 25-gauge nee- 
dle, the homogenate extracted with a mixture of phenol- 
water/chloroform-isoamilic alcohol/sodium acetate, pH 
4(1,1/2=1/15), and the aqueous phase selectively precipi- 
tated with isopropanol. The pellet was resuspended in 
solution D, reprecipitated with isopropanol and digested 
with 100 #g/ml proteinase K in 0.3 M sodium acetate, pH 
6,1 mM EDTA, 0.1% SDS. The RNA was phenol extracted, 
ethanol precipitated, resuspended in sterile diethylpyro- 
carbonate (DEP)-treated water, and stored at -80 °. 
To obtain nuclear and cytoplasmic RNA, the method 
described by Sambrook et al. (1989) was modified to 
minimize viral DNA contamination. Cells washed in cold 
PBS were resuspended (4 x 106 cells per milliliter) at 4 ° 
in0.14 M NaCl, 1.5 mM MgCI2, 10 mM Tris, pH 8.6, 1% 
NP-40, 40 u/ml RNasin (Boehringer, Clontech) and lysis 
controlled under microscope. The suspension was cen- 
trifuged at 400 g and 4 ° for 5 min, and the nucleus was 
washed once more in the same lysis solution. The super- 
natant was collected as cytoplasmic fraction, digested 
with 200 #g/ml proteinase K in 100 mM Tris, pH 7.5, 12.5 
mM EDTA, 150 mM NaCI and 1% SDS at 37 ° for 30 min, 
phenol-extracted, and ethanol-precipitated. Cytoplasmic 
RNA pellet was further purified by resuspension in solu- 
tion D and selective isopropanol precipitation as de- 
scribed above. To the nuclear pellet of 107 cells, 2 ml of 
solution D and 40 #g of Escherichia coil  ribosomal RNA 
(Boehringer), to favor quantitative recoveries, were 
added. The lysate was selectively precipitated twice (see 
AGPC method above) and digested with 200 units of 
DNase I RNase free (Boehringer) in 10 mM NaCI, 6 mM 
MgCI2, 40 mM Tris, pH 7.5, for 30 min at 37 °, Finally, 
nuclear RNA was proteinase K-digested, phenolized, eth- 
anol-precipitated, and resuspended in 10 #1 of H20 per 
106 processed cells. In all cases the RNA concentration 
was quantitated by absorbance at 259 rim. The integrity 
of the samples was routinely ascertained by methylen 
blue staining of the ribosomal RNA (carrier E. coi l  in 
the nuclear preparation, eucaryotic in the rest) blotted to 
membranes as described below, and by hybridization 
with a mouse fl-actin probe as indicated in the figure 
legends. 
RNA analysis 
For Northern blotting, total RNA was denatured with 
formamide, electrophoresed in 1% agarose gels in MOPS 
buffer with 6% formaldehyde, and blotted onto nylon 
membranes (Gene Screen Plus, Dupont). The blots were 
hybridized with DNA probes labeled with [32P]dCTP by 
random priming to a specific activity of 109 cpm/#g, or 
with sense RNA probes synthesized in vitro as described 
below. Hybridizations were performed for 24 hr at 42 ° 
in 50% deionized formamide, 5x SSC, 5× Denhardt's 
solutions, 1% SDS, and 10% dextran sulfate (Pharmacia), 
and filters were washed at 56 ° in 0.1X SSC, 0.5% SDS 
three times each hour. Filters were dried and exposed 
to Kodak X-OMAT film for the indicated time periods. 
For the RNase protection assays, the method of Zinn 
et al. (1983) was adapted with some modifications. The 
Ncol(1901)-Pstl(2130) restriction fragment of the MVMp 
genome was cloned in the pGEM vectors (Promega) and 
riboprobes were synthesized from the SP6 promoter by 
standard procedures, using 50 #Ci [32p]UTP 400-800 Ci/ 
nmol (Amersham, NEN) and up to 40 #M UTP in a final 
volume of 20 #1. Recoveries were commonly 300 ng of 
a 3.5 X 103 #Ci/nmol sp act riboprobe. For quantitative 
estimation of the viral messengers' abundance, the reac- 
tions were performed under an excess of probe drying 
under vacuum 2.5 x 106 cpm (25 ng) of probe together 
with 3 #g of total or cytoplasmic RNA, or nuclear RNA 
from an equivalent number of cells supplemented up to 
3 #g with E. coi l  rRNA. The mixture was redissolved in 
30 #1 of 80% deionized formamide, 40 mM PIPES (pipera- 
zine-N,N'-bis 2-ethanesulfonic acid), pH 6.4, 400 mM 
NaCI, and 1 mM EDTA, denatured at 85 ° for 10 min, and 
hybridized at 45 ° for 18 hr. The unhybridized probe was 
digested in 350 #1 of 10 mM Tris, pH 7, 5 mM EDTA, and 
300 mM NaCI with RNaseA (28 #g/ml) and T1 (500 u/ml) 
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at 25 ° for 45 min. To inactivate the RNases 20 #1 of 10% 
SDS and 40 fig of predigested proteinase K were added, 
the sample was incubated at 37 ° for 30 min, and RNA 
was extracted with phenol and precipitated with ethanol 
in the presence of 2 #g carrier E. col~ tRNA (Boehringer). 
Samples were redissolved in 20 #1 of loading buffer (80% 
formamide, 40 mM Tris-borate, pH 7, 0.2% bromophenol 
blue and xylencyanol) heated at 100 ° for 5 min, and elec- 
trophoresed in denaturing 6% polyacrylamide gels. Gels 
were dried and exposed to autoradiography with intensi- 
fying screen. Molecular weight markers Were restriction 
fragments of the pUC19 plasmid digested with Mspl and 
labeled with Klenow polymerase. Transcript abundance 
was estimated using a Molecular Dynamics 300A densi- 
tometer. The RNA secondary structure was predicted by 
the STEMLOOP and FOLD programs of the GCG Pack- 
age version 7 software (Genetics Computer Group, Inc.). 
DNA isolation and analysis 
Cellular genomic DNA was isolated by digesting 
washed cell pellets with 100 #g/ml proteinase K in 10 
mMTris, pH 7.4, 10 mM EDTA, 150 mM NaCI, 0.5% SDS 
at 37 ° for 2 hr, followed by phenol extraction and ethanol 
precipitation. MVMp DNA was isolated by a procedure 
based on the Hirt's method to enrich in low-molecular- 
weight DNA (McMaster et aL, 1981). Plasmid integration 
in the genome of the transfected clones and intermediate 
replicative forms of the virus were analyzed by electro- 
phoresis in agarose gels, alkali-blotted to nylon mem- 
branes, and hybridized as described above. 
Two-dimensional gel electrophoresis and protein 
quantification 
Our method to analyze the synthesis and post-transla- 
tional modifications of the MVMp proteins has been de- 
scribed (Santar6n et al., 1993). In brief, infected or unin- 
fected A9 cells were labeled 12-16 hpi with 1 mCi/ml of 
3~S-Met (Amersham SJ5050) in methionine free medium 
supplemented with 5% dyalized FCS, and the scrapped 
monolayers submitted to equilibrium two-dimensional 
gel electrophoresis (IEF). Gels were processed for fluo- 
rography and exposed to Kodak X-Omat films at -70 °. 
The quantitative analysis of the protein patterns was per- 
formed using the PDQUEST V 4.1 software (Protein Data- 
base, Inc.). Display windows were chosen to reflect accu- 
rately the relative signal intensities in the autoradiograms 
of the MVMp proteins with respect to a random collection 
of surrounding cellular protein spots. The reproduction 
of all aspects of this 2D gel analysis by using the QUEST 
program has been addressed by Garrels (1988). 
RESULTS 
A constitutively expressed NS-1 antisense confers 
resistance against MVMp infection in A9 cells 
A molecular clone of the MVMp virus was obtained 
from replicative intermediates of infected A9 cells as de- 
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FtG. 1. Construction of the pSkNS-1 a plasmid to express an antisense 
RNA targeted against the NS-1 protein of the parvovirus MVMp. The 
genomic organization of the MVMp is shown in the upper diagram 
(based on Cotmore and Tattersall, 1987). To simplify the figure, minor 
alternate splicings and proteolitic VP-2 processing have been omitted. 
The arrows indicate the positions of the two viral promoters, and the 
coding regions have been drawn in boxes at the respective reading 
frame. The NS-1 specific region cloned in the antisense direction is 
represented by thick line below, flanked by the HSV-1 timidin-kinase 
promoter and the SV40 enhancer control elements (SVe-tk), and a 340- 
bp PstI-BamHI fragment containing the 3' noncoding region (3' NCS) 
of a p27 full-length cDNA clone. 
scribed under Materials and Methods. To express an 
NS-1 specific antisense RNA, the large intron of the virus 
genome expanding a Pvull (762)-Ncol (1987) 1.2-kbp 
DNA fragment was cloned in the antisense direction un- 
der the control of the HSV-1 tk promoter and the SV40 
enhancer. This sequence is transcribed only in the R1 
RNA that codes for the NS-1 polypeptide (see Fig. 1). 
Among many factors that may influence a constitutive 
and durable expression of an antisense RNA, three were 
taken into account in this construct. First, the predicted 
secondary structure of this RNA (Materials and Methods) 
did not contain long stretches of base pairing that could 
impair transcription or stability. Second, the SVe-tk cas- 
sette proved to be a powerful and stable promoter in A9 
cells, as judged from the high and sustained expression 
of E. coil/~-galactosidase and MVM capsid proteins (to 
be described elsewhere). Third, a 3' noncoding se- 
quence of a p27 actin-associated protein cDNA corre- 
sponding to a mRNA highly stable in mouse fibroblasts 
(Almendral et al., 1989) was inserted 3' downstream of 
the antisense as a putative stabilizing element. The final 
NS-1 antisense expressing plasmid is referred to as 
pSkNS-la (Fig. 1). 
The selectable marker pSV2neo and a 10-fold molar 
excess of the pSkNS-la plasmid were cotransfected in 
A9 cells and single clones selected for geneticin resis- 
tance. When 20 transfectants were analyzed for plasmid 
integration, every one harbored one or several copies of 
the pSkNS-la plasmid in their genomes (data not shown). 
As a primary estimation of whether the NS-1 antisense 
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FiG. 2. Quantitative measurement of clones' resistance against MVMp cytopathic effects. (A) Staining method. Exponentially growing clones were 
infected at low m.o.i, and 6 dpi cell density was measured by staining attached cells with crystal violet. Represented is the percentage of A57o of 
the eluted dye per dish, relative to the corresponding uninfected culture seeded and procedured similarly. The blank bar indicates the mean value 
for the initial population of A9 cells. (B) Cellular viability method. Cell menolayers were infected at the indicated m.oJ. and plated to test their 
proliferative capacity by a clonogenicity assay. The survival plot represents the percentage of colonies obtained at each m.o.i, relative to the number 
formed in the uninfected cultures. For the sake of being explicit, clone 23 and 24, which gave curves similar to that of clone 14, have not been 
represented, pSkNS-la-transfected clones are represented by closed circles. Reference cells (NIH3T3, A9 and clones nee r 2, 17 and 21) are 
represented by open circles. In both assays, each value is an average of at least two independent determinations. 
could confer any resistance against the cytopathic effect 
0fthe MVMp infection, a large number of randomly iso- 
lated untransfected clones (A9) and geneticin resistant 
clones, either stably transfected with the pSV2neo plas- 
mid alone (nee) or cotransfected with the antisense ex- 
pressing pSkNS-la plasmid (NS-la), were plated at low 
density, infected with 0.1 PFU/cell, and incubated for 6 
days. An indirect measurement of the remaining adher- 
ent cells after this time was obtained by the staining 
method explained under Materials and Methods. We 
found (Fig. 2A) that untransfected A9 clones stained to 
values in the range of 1- to 21fold of the average of the 
population (5%Ae7e), an indication of a low but somehow 
heterogeneous resistance to MVMp in the original cells. 
Transfectant clones also behaved heterogeneously, but 
here some of them reached higher staining values. While 
5 out of the 43 analyzed nee clones stained above 3- 
f01d (more than 15% A57o) the value of the A9 control 
population, this proportion increased in the NS-la group 
to 10 out of the 47 analyzed. However, we observed that 
in some cases dishes with most cells showing an obvi- 
ous cytopathic effect stained nevertheless to values 
above control, suggesting that this method may not al- 
ways be adequate to determine anti-MVMp resistance 
f0rthe A9 cells. Thus, a more reliable parameter of resis- 
tance, like the preservation of cell proliferative capacity 
upon virus infection, was tested in our system. This 
method is based .on determining the fraction of cells that, 
once exposed to different multiplicities of infectious virus, 
remain viable enough to develop macroscopic colonies 
after several days in culture (see Materials and Meth- 
ods). Figure 2B displays the viability curves obtained for 
a representative collection of transfectant clones. All un- 
infected clones showed similar cloning efficiencies 
(around 50%) irrespective of the transfecting plasmid and 
of the selection step. The clones with low staining values 
(nee 2, nee 21, and the NS-la.5, 7, 21 and 46) showed 
viability curves consistently lower than or equivalent to 
that of the A9 cells. Remarkably, the high staining values 
of some clones (nee 17 and the NS-1a.25 and 45) were 
not supported by viability curves above the control. How- 
ever, other clones did demonstrate viability curves signifi- 
cantly higher than that of the A9 cells. They all belonged 
to the group transfected by the pSkNS-la plasmid. These 
clones (NS-la.10, 13, 14, 16, 23, 24, 34, 39, and 41) 
showed a proliferative capacity upon MVMp infection 
three to eight times higher than that of parental A9 cells, 
and about five times lower than that of the naturally resis- 
tant NIH3T3 cells. 
We next studied whether the resistance against the 
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correlation between these two properties could not be 
established. Hence, some poorly resistant clones dis- 
played moderate to high-level antisense expression (3, 
20, 30), while some of the low expressing clones (10, 23, 
24, 39, 41) behaved as trustworthy resistant. 
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FIe. 3. Antisense RNA expression in the pSkNS-la-transfected 
clones. Total RNA (15 #g) of the indicated transfected clones was 
fractionated on denaturing agarose-formaldehyde gels, blotted to 
membranes, and hybridized with a MVMp Pvull (762)-Ncol (1897) 32p_ 
DNA probe. (a) Fifteen micrograms of RNA of clone 3 hydrolized with 
alkali (0.3 N NaOH, 30 min at 37 °, and neutralized with 0.3 N HCI, 10 
mM PIPES, pH 6.4); (D) 15 /~g RNA of the same sample digested with 
40 units of DNase RNase-free (Boehringer) at 37 ° in 20 #1 of 10 mM 
NaCI, 40 mM Tris, pH 7.6, and 6 mM Mg2Cl for 30 min. Below, 4 #g 
of the same samples probed for fl-actin expression. Exposures lasted 
4 days at -70 ° with intensifying screen, except for clones 10, 23, 24, 
39, 41, and 46 which were xposed for 10 days and the fl-actin blot 
that was exposed at room temperature for 6 hr. Overexposures of 
clones 5, 7, 21,26, and 46 did not show any signal of antisense xpres- 
sion (not shown). The positions of the ribosomal RNA markers as 
stained in the same filters are indicated on the right. 
MVMp correlated with the transcription of the antisense 
in the clones. Total RNA was isolated and the level of 
expression of the NS-1 antisense determined by North- 
ern blot. A representative result of the analyzed samples 
is shown in Fig. 3. Double-stranded MVM DNA as well as 
strand-specific RNA probes gave a reproducible complex 
pattern of antisense expression composed of several dis- 
tinct high-molecular-weight bands and a tow-molecular- 
weight RNA smear in all the clones. This pattern was 
consistent over repeated passages of the cells, and was 
due to RNA according to the alcali hydrolisis and DNase 
digestion tests (see legend to Fig. 3). Interestingly, we 
found a good qualitative correlation between the expres- 
sion of antisense and the resistance determined by pro- 
liferative viability, the six susceptible NS-la clones as- 
sayed showed no detectable levels of antisense (5, 7, 
21, 25, 45, 46), but all the significantly resistant clones 
did express antisense to NS-1 (10, 13, 14, 16, 23, 24, 34, 
39, 41). This study suggests that the synthesis of NS-1 
antisense is the factor that determines the MVMp-resis- 
tant phenotype in the clones, albeit a linear quantitative 
NS-1 antisense inhibits MVMp but not unrelated 
viruses 
To gain data on the protective effect conferred by the 
NS-1 antisense against the MVMp under conditions that 
may resemble low-multiplicity, naturally occurring infec- 
tions, several antisense expressing and control clones 
seeded at low density were infected by 0.01 PFU/cell of 
MVMp, and the progression of the cytopathic effect was 
evaluated. All uninfected clones showed a similar growth 
rate and reached a cell density like the A9 control cells 
(Fig. 4), which demonstrates that the constitutive xpres- 
sion of the NS-1 antisense is not harmful for these fibro- 
blast cells. However, infected cultures behaved unevenly. 
In the A9, the number of viable cells decreased sharply 
from the third day postinfection (dpi) in correspondence 
with a generalized cytopathic effect (Fig. 4, right). Simi- 
larly, the number of adherent viable cells in the control 
clones (neo 2, neo 17) and the susceptible pSkNS-la 
transfected clones 20 and 34 declined from the fourth 
dpi. On the contrary, cultures of the two clones NS-la.10 
and NS-1a.13 that expressed antisense and were prolif- 
erate among the most resistant to the MVMp infection 
displayed growth kinetics and reached a cell density 
close to the respective uninfected cultures. When cells 
were analyzed for viral antigens synthesis (Fig. 4, lower 
right), MVMp multiplication was restricted to a small frac- 
tion of the NS-1a.13 cells, in sharp contrast with the 
general positive staining for capsid protein synthesis in 
the control A9. 
RNA-mediated resistance is a sequence-dependent 
mechanism, and therefore the NS-1 antisense should not 
inhibit other viruses unrelated to MVMp. To prove the 
specificity of the inhibition, different desoxi and ribovi- 
ruses that replicate in the nucleus or in the cytoplasm 
of the mouse fibroblasts (HSV-1, EMCV, and VSV), and 
do not share long stretches of homologous sequences 
with the parvoviruses, were tested by a plaque assay on 
A9 and antisense expressing cells. As shown in Fig. 5, 
none of the unrelated viruses was interfered by the NS- 
1 antisense on any of the clones. On the contrary, the 
number of MVMp plaques was reduced by a factor of 10 
to more than 20 when assayed respectively on low (NS- 
la. 20) or high (NS-la. 13) resistant clone. A size reduc- 
tion of the plaques was also noticed. This result suggests 
that the antiviral effect of the NS-la antisense is being 
accomplished by a specific and sequence-dependent 
mechanism. 
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FIG. 4. Inhibition of MVMp propagation in cell lines expressing NS-1 antisense. Established cultures of A9 cells, nee 17 and nee 2 clones, and 
NS-la clone 10, 13, 20, and 34, were infected at m.o.i. 0.01 PFU/cell and monitored for the progression of the MVMp infection during a week. The 
figure represents the number of adherent viable cells trypsinized and counted by the trypan blue exclusion criteria. Two 60-mm dishes were 
processed per point and the experiment was repeated twice with essentially identical outcomes. To the right, representative fields by Day 5 
p0stinfection ofviral-mediated ffects on cell density and morphology, and an indirect in situ immunofluorescence of the capsid proteins ynthesis 
in the cultures, are illustrated. Magnification, x400. 
MVMp macromolecular synthesis is impaired by NS-1 
antisense 
The inhibitory effect that the NS-1 antisense deter- 
mines on MVMp cytotoxicity and multiplication implies 
that an impairment of the virus macromolecular synthesis 
was taking place in the resistant clones. To determine 
which is the major step of the virus cycle being inhibited, 
we monitored in sensitive and resistant clones the level 
0fviral DNA, RNA, and protein synthesis in a single round 
0finfection at a multiplicity of 5 PFU/ceI1. The accumula- 
tion of the MVMp messengers at 14 hpi was determined 
by an RNase protection assay with a riboprobe selected 
outside the antisense region to avoid endogenous inter- 
ference, which generates protected fragments of 230, 
140, and 121,125 nucleotides for the R1, R2, and R3 viral 
transcripts, respectively (Fig. 6, left). As illustrated in the 
figure, a drastic reduction in the steady-state levels of 
all three viral messengers was observed in the resistant 
NS-la.10 and 13 clones when compared with the control 
A9 cells. Likewise, the viral DNA synthesis was found 
inhibited proportionally to the resistance. Low-molecular- 
weight DNA isolated at 2 and 16 hpi was blot hybridized 
(Fig. 6, upper right). While the signals at 2 hpi of cell- 
associated input viral genomes were similar, a restriction 
rn the capacity of the virus to originate replicative inter- 
mediates and mature genomic forms at 16 hpi was ob- 
served only in clones expressing antisense RNA. 
To estimate accurately the MVMp inhibition at the pro- 
tein level, we pulse-labeled 12-16 hpi monolayers of the 
NS-la.10, 13, 20 clones and of two controls (A9 cells 
and the nee 17 clone), and proteins subjected to two- 
dimensional gel electrophoresis in parallel with samples 
of the respective uninfected cultures. No significant 
changes in the patterns of cellular proteins were found in 
any of the uninfected clones, what supporting the above- 
mentioned harmless effect of the NS-1 antisense expres- 
sion on the cells growth. As a representative result of 
these experiments, Fig. 6 (lower right) displays the 2D 
pattern of proteins resolved at equilibrium for the A9 and 
NS-la.10 cells infected by MVMp. Since only a small 
proportion of unsynchronously growing A9 cells are ex- 
pected to be productively infected by MVMp at 16 hpi, 
the relative abundance of the different MVMp proteins 
was quantified with respect to a reference collection of 
cellular proteins (see Materials and Methods). The induc- 
tion of all the reference MVMp-eoded proteins, rather 
than NS-1 alone, was remarkably reduced in the anti- 
sense expressing clone. In the whole study, the reduction 
ranged in average between 90% for the NS-la.10 to 40% 
for the NS-la.20 clone with respect to the controls (A9 
cells and the nee 17 transfectant). 
The NS-1 antisense inhibitory effect on MVMp 
transcription is exerted inside the nuclear 
compartment 
The mechanism underlying the NS-1 antisense-medi- 
ated inhibition of viral mRNAs accumulation may act pref- 
erentially or be confined within a subcellular compart- 
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FIG. 5. Specificity of the NS-1 antisense inhibition. Monolayers of A9 
cells and of the NS-1a.13 and NS-la.20 clones seeded at densities of 
2 x 105 (HSV-I), 3 x 105 (MVMp), or 8 X 105 (VSV, EMCV) cells per 
60-mm dish were inoculated with a unique suspension of the indicated 
virus in PBS, allowed to adsorb for 1 hr at 37 ° with periodic rocking of 
the dishes, and overlaid with semisolid medium. After the correspond- 
ing incubation times the cells were fixed, then stained with 0.2% crystal 
violet, and the number of plaques was scored in triplicate. The figure 
shows the plaque-forming efficiency of the viruses on each clone. The 
plaque size of HSV-1 was too small to be seen clearly in the photo- 
graph. An average stimation, given as a percentage of the number of 
plaques from two experiments, is indicated by the bars below. 
ment of the infected cells. That would be the case if the 
antisense decreased the stability of the messengers in 
the cytoplasm or their nuclear-cytoplasmic transport. To 
investigate this possibility, a collection of clones and 
control cultures was infected and subjected to a nuclear- 
cytoplasmic fractionation, and the respective purified 
RNAs were analyzed by the RNase protection assay de- 
scribed above. As explained under Materials and Meth- 
ods, an excess of probe was used to guarantee a quanti- 
tative analysis and the relative abundance determined 
by densitometric scanning of the autoradiograms. We 
found again a general inhibition in the steady-state levels 
of the three viral transcripts (see Fig. 7). Inhibition factors 
averaged for the three viral messengers were approxi- 
mately 20-fold for the NS-la.10 clone, 10-fold for the NS- 
la.13, and 3-fold for the NS-la.20, with respect to con- 
trols (A9 and the neo 17 transfectant). These numbers 
were comparable in both subcellular compartments, as 
neither an increased accumulation of the viral transcripts 
in the nucleus nor a preferential degradation in the cyto- 
plasm was found to occur significantly in any of the 
clones. Therefore, the expression of the NS-1 antisense 
acts as a negative regulator of the intranuclear accumu- 
lation of viral transcripts. 
DISCUSSION 
We have tested an antisense approach against the 
MVMp virus, aimed toward the development of genetic 
interference models for the control of parvoviruses and 
other cytolitic viral infections. Our interest was focused 
on achieving a constitutive, lasting expression of an inno- 
cous antisense RNA that would curtail specifically MVMp 
cytopathogenicity and multiplication at an early stage of 
the virus life cycle. 
Cell resistar~ce against MVMp infection was evaluated 
by two procedures, staining adherent cells and determin- 
ing proliferatively viable cells. The former became a prac- 
tical method to rule out nonresistant candidate clones, 
but nonviable cells from some clones remained adhered 
to the dishes yielding staining values above controls. 
Although the nature of this residual adherence remains 
unclear, it might be related to any of the phenomena that 
accompany the interactions of parvoviruses with their 
host cells, like coevolution (Ron and Tal, 1985), per- 
turbance of the cell cycle (Winocour et aL, 1988), or toler- 
ance to viral cytotoxic products (Caillet-Fauquet et al., 
1990). The latter procedure allowed ultimately the dis- 
crimination of the antisense-mediated resistance, be- 
cause only clones that express NS-1 antisense were 
able to proliferate upon MVMp infection between three 
to eight times more than the controls; this capacity corre- 
lated with a proportional specific inhibition of virus mac- 
romolecular synthesis. 
The pattern of the NS-1 antisense transcription reflects 
a length heterogeneity and perhaps some unstability 
which may be due to the fact that he 3'NCS cDNA frag- 
ment inserted 3' downstream of the antisense lacked 
transcription termination and poly A addition signals. The 
design of this construct was based primarily on previous 
reports about antisense RNAs that, lacking transcription 
termination signals, were effective in other systems 
(Crowley et aL, 1985; Khokha et al., 1989; Knecht and 
Loomis, 1987) and on the possibility that this 3'NCS 
could enhance antisense stability, given the current un- 
certainties on determinants of stability for a nontranslat- 
able RNA inside an eukaryotic cell (Hentze, 1991; Sachs, 
1993). This notion was supported by preliminary experi- 
ments in which the same NS-1 antisense transcribed 
from the same promoter, but without this 3' cDNA frag- 
ment, remained undetectable in RNA blots of transfected 
A9 cells (data not shown). 
We were unable to detect a linear relationship be- 
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t:16. 6. MVMp macromolecular synthesis under NS-1 antisense expression. Left: Steady-state levels of viral mRNAs determined by a  RNase 
protection assay with total RNA. (A) The position of the riboprobe in the MVM genome and the size of the protected fragments i  the virus 
messengers are indicated. (B) Autoradiogram of a polyacrylamide gel showing the level of the three viral mRNAs (R1, 2, R3) in the indicated 
clones; control, a 32P-labeled riboprobe synthesized from a MVMp Pvull (761)-EcoRI (1081) fragment added to the samples after the RNase digestion 
as internal control of recoveries. (C) The same samples probed for fl-actin in a Northern blot. Upper right= MVMp DNA replication in antisense 
expressing clones. Alkali blots of viral DNA isolated from 2.5 × 104 infected cells and hybridized with a MVMp full-length probe. Samples were 
also standardized by an internal control riboprobe. The monomeric (mRF) and dimeric (dRF) replicative intermediates, and the genomic ssDNA 
forms free (ss) or bound to NS-1 (ss*) are indicated on the right. Exposures were for 2 or 24 hr for samples harvested at 16 or 2 hpi, respectively. 
Lower ight, MVMp protein synthesis inhibition by NS-1 antisense. Autoradiograms of two-dimensional gels (IEF) from the NS-la. 10 clone and A9 
cells pulse-labeled 12-16 hpi with [36S]methionine. The positions of the MVMp-coded proteins (Santar6n et aL, 1993) are indicated by arrows. Gels 
were loaded with 1 × 106 cpm and exposed for 48 hr (to detect the NS-1 and VP-2 proteins) and for 5 days (to detect the NS-2 isoferms). The pH
ranges of the selected regions from the gels are displayed below, and molecular weights are shown to the right. 
tween the degree of antisense expression and the con- 
ferred resistance. A lack of correlation among antisense 
levels and phenotypic effects has also been consistently 
noticed in other systems (see for example Khokha et al., 
1989) and it was attributed to a different location of sense 
and antisense sequences in the genome (Kim and Wold, 
1985). Given that MVMp replication is subnuclearly com- 
partimentalized (Walton et aL, 1989), clones in which the 
antisense is transcribed at these compartments may 
show an enhanced resistance since a higher local con- 
centration of antisense and target RNAs would favor the 
reaction, 
MVMp transcripts accumulate to high levels in the 
permissive A9 cells (Schoborg and Pintel, 1991), making 
it difficult to reach the high ratio of antisense to sense 
RNA required for an efficient inhibition (Kim and Wold, 
1985). To overcome this problem, we targeted the consti- 
tutively expressed antisense RNA against the messenger 
of the transcriptional transactivator NS-1 protein, in order 
to get a favorable excess of antisense molecules at the 
early stages of MVMp transcription. According to this 
strategy, all resistant antisense expressing clones 
showed significant reductions (50-95%) in the viral DNA 
replication, steady-state abundance of messengers in 
the nucleus and cytoplasm, and proteins synthesis. Be- 
cause the NS-1 antisense can hybridize only with the R1 
messenger (see Fig. 1), the observed inhibition of all 
three viral transcripts cannot be a direct consequence 
of the action of the antisense mechanism but rather a 
subsequent pleiotropic effect obtained by repressing the 
multifunctional NS-1 protein expression. This polypeptide 
regulates several steps of the virus life cycle, such as 
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long-term antiviral state to treat life-threatening infec- 
tions. With the parvovirus MVMi, a strain very similar to 
the one used in this report (Astell et al., 1986) but with 
a wide lymphohemopoietic tropism in the mouse that 
includes T lymphocytes (Engers et aL, 1981) and hemo- 
poietic progenitors (Segovia etaL, 1991), we have a chal- 
lenging system that could enable us to evaluate the effi- 
cacy of a constitutive NS-1 antisense in vivo. 
ACKNOWLEDGMENTS 
We thank Jean Rommelaere and Jan Cornelis for experimental advice 
and helpful criticism, and Bernhard Hirt and Juan Ortin for useful sug- 
gestions on the manuscript. We also thank I. Orm~n for excellent echni- 
cal assistance, and J. A. Bueren and J. L. Jorcano for encouragement 
and laboratory support. This work was supported by grants from the 
Comisi6n Interministerial de Ciencia y Tecnologia CtCYT (SAF92-1014- 
C02-01) and the Commission of the European Communities (BMH1- 
0T92-0629), and from an institutional grant of Fundaci6n Ram6n Areces 
to the Centro de Biologia Molecular "Severo Ochoa." J.C.R. was a pre- 
doctoral fellow of the MEC. 
FiG. 7. Subcellular distribution of MVMp messengers in the NS-1 
antisense expressing clones. Cell monolayers were infected by 5 PFU/ 
cell of MVMp, and 14 hpi nuclear and cytoplasmic RNA were purified. 
An RNase protection assay was performed for each clone with 3 #g 
of cytoplasmic RNA, and the nuclear RNA from the same number of 
cells. A9 2X, Probe excess control with 6 #g of cytoplasmic RNA from 
infected A9 ceils. Uninfected= cytoplasmic RNA from A9 cells processed 
similarly. AIcali: 3 #g RNA of infected A9 hydrolyzed with 0.3 N NaOH 
for 30 min at 37 ° before hybridization. Quantitative recoveries were 
controlled by an internal riboprobe as in Fig. 6. Exposures were 
for 48 hr. 
the activity of the early and late promoters, viral DNA 
amplification, and genome encapsidation (see for exam- 
ple Cotmore and Tattersall, 1992; Doerig et aL, 1988; 
Hanson and Rhode, 1991). Thus for the small and func- 
tionally integrated MVM genome, the targeted NS-1 anti- 
sense becomes a general negative regulator of viral 
gene expression and replication. It is noteworthy to re- 
member that a similar overall decrease in viral transcrip- 
tion was also obtained for the human immunodeficiency 
type 1 virus (HIV-1) by an RNA-mediated strategy that 
sequestered a protein complex (Sullenger et aL, 1991). 
The parvoviruses are responsible for severe syn- 
dromes in immunocompromised hosts and of abortion 
and malformation in developing humans and animals 
(Siegl, 1988; Tijssen, 1990). The human B19 parvovirus 
causes chronic and at times fatal bone marrow failures 
in immunocompromised patients or individuals with ac- 
celerated erythropoiesis (Kurtzman et aL, 1989; Pattison, 
1988). Genetic tools against parvoviruses may eventually 
lead to the development of transgenic resistant animals 
as has been exemplified in other viral systems (Arnheiter 
etaL, 1990; Han etaL, 1991), orto a somatic gene therapy 
(Baltimore, 1988) in which human hemopoietic stem cells 
may be transduced with resistance genes to establish a 
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